政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/59389
English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  全文筆數/總筆數 : 113451/144438 (79%)
造訪人次 : 51289461      線上人數 : 1005
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋


    請使用永久網址來引用或連結此文件: https://nccur.lib.nccu.edu.tw/handle/140.119/59389


    題名: 優化行銷有效性-以藥品行銷市場為例
    Optimize Marketing Effectiveness in Pharmaceutical Industry
    作者: 戴綻鈴
    Dai, Irene
    貢獻者: 吳文傑
    Wu, Jack
    戴綻鈴
    Dai, Irene
    關鍵詞: 優化
    行銷有效性
    藥品市場
    Optimization
    Marketing Effectiveness
    Pharmaceutical Industry
    日期: 2012
    上傳時間: 2013-09-02 16:16:33 (UTC+8)
    摘要: Measuring marketing effectiveness is critical for marketers as the pharmaceutical industry is under great pressure for cost control. Pharmaceutical marketers need to optimally allocate these resources and ensure that they achieve the highest possible return on investment for the firm. Pharmaceutical manufacturers utilize a variety of marketing vehicles to promote their products to physicians and consumers. At the physician level, effects of detailing are typically identified to be positive. Direct- to-consumer advertising does impact the choice probability, but the impact of promotions aimed directly at physicians is significantly higher. Measuring value of marketing activities is important for a company to achieve a profit margin and best allocate its resources. To define and deliver quantitative measurements that justify how investment in specific marketing programs are paying off, marketers need metrics to show that their programs work. Then, selected metrics should be meaningful and related to financial performance. There are a few metrics regularly used by marketers such as brand awareness, market share, consumer attitudes toward brand, purchase intention, return on investment, lifetime value of an activity, and brand equity. The paper uses a case study to review and evaluate the effectiveness of a marketing plan for a new launch product. Specifically, return on investment (ROI) for patient programs and lifetime value of activity (LVA) for physician education programs were calculated in the case study. A company is able to increase sales profit by reallocating resources to activities with higher ROI and LVA. To conclude, marketers need to identify meaningful metrics, set up a tracking process, and regularly follow up all relevant marketing activities. The process of measuring marketing effectiveness through the tracking process will help companies to understand how the marketing activities work and whether these programs deliver profitable value growth. The follow up action to fine-tune budget plans can then optimize return of marketing investment and maximize profitability.
    1. Introduction 1
    2. Pharmaceutical Marketing Activities 3
    2.1. Effect of Single Promotion Activity 5
    2.1.1. Detailing 5
    2.1.2. DTC 6
    2.1.3. Comparison of Different Promotion Activity 7
    2.2. Interaction Effect of Promotion Activities and Marketing Mix Model 7
    3. Measuring Marketing Effectiveness 9
    3.1. ROI in Pharmaceutical Marketing 9
    3.2. Defining Meaningful and Manageable Metrics 9
    4. Case Study 12
    4.1. Overview of the Health Market in Taiwan 12
    4.1.1. Healthcare System 12
    4.1.2. Healthcare Expenditure 13
    4.1.3. Pharmaceutical Market in Taiwan 13
    4.2. Background of the Case 14
    4.3. Measuring Marketing Effectiveness 17
    4.3.1. Use Metrics to Review Marketing Effectiveness Results 20
    4.3.2. Optimize Marketing Effectiveness 23
    5. Conclusion 25
    Reference 33
    參考文獻: Ackerly, D.C., Glickman, S. and Schulman, K.(2010). Economic content in medical journal advertisements for medical devices and prescription drugs. Pharmacoeconomics, 28(2), 429-38.
    Bates, A. (2008). Using ROI data for effective decision making in pharmaceutical marketing. Eularis Report.
    Berndt, E. R., Bui, L., Reiley, D. R., & Urban, G. L. (1995). Information, marketing, and pricing in the U.S. antiulcer drug market. American Economic Review, 85(2), 100−105.
    Brekke, K. and Kuhn, M. (2006). Direct to consumer advertising in pharmaceutical markets. Journal of Health Economics, 25(1), 102-30.
    Caleb, A., Zhang, J. and Basu, A. (2008). Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs. Medical Care, 46(4), 394-402.
    Chao,T.F., Liu, C.J.,Chen, S.J., Wang, K.L.,Lin, Y.J., Chang, S.L.,Lo, L.W, Hu, Y.F.,Tuan, T.C.,Wu, T.J.,Chen, T.J.,Tsao, H.M., Chen, S.A. (2012). Atrial fibrillation and the risk of ischemic stroke: does it still matter in patients with a CHA2DS2-VASc score of 0 or 1? Stroke, 43(10), 2551-5.
    Connolly, S.J., Ezekowitz, M.D., Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L. RE-LY Steering Committee and Investigators(2009). Dabigatran vs. warfarin in patients with atrial fibrillation. N Engl J Med, 361, 1139–1151.
    Cutrona, S., Woolhandler, S., Lasser, K., Bor, D., McCormick, D. and Himmelstein, D. (2008). Characteristics of recipients of free prescription drug samples: a nationally representative analysis. American Journal of Public Health, 98(2), 284-9.
    Ding, M., & Eliashberg, J. (2008). A dynamic competitive forecasting model incorporating dyadic decision making. Management Science, 54(4), 820−834.
    Donohue, J. M., & Berndt, E. R. (2004a). Effects of direct-to-consumer advertising on medication choice: the case of antidepressants. Journal of Public Policy & Marketing, 23(2), 115−127.
    Donohue, J.M., Berndt, E.R., Epstein, A.M., Frank, R.G., (2004b). Effects of Pharmaceutical Promotion on Adherence to Guideline Treatment of Depression. Medical Care, 42(12), 1176–1185.
    Donohue, J., Cevasco, M. and Rosenthal, M. (2007). A decade of direct-to-consumer advertising of prescription drugs. New England Journal of Medicine, 357(7), 673-81.
    Gagnon, M. A., & Lexchin, J. (2008). The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. Plos Medicine, 5(1), 29−33.
    Garnder, D., Mintzes, B. and Ostry, A. (2003). Direct-to-consumer prescription advertising in Canada: permission by default? Canadian Medical Association Journal, 169(5), 425-7.
    IMS Health Annual Report (2007), available at: http://library.corporate-ir.net/library/67/671/67124/items/285451/IMS2007AnnualReport.pdf.
    IMS Health Annual Report (2010), Total US promotional spend by type, 2009, available at: www.imshealth.com/deployedfiles/imshealth/Global/Content/StaticFile/Top_Line_Data/PromoUpdate2009.pdf.
    IMS Health Annual Report (2013), IMS Market Prognosis 2013-2017 report.
    Jin, H., Ryan, J., Vail, S. (2008) Assessing the Impact of Unmodeled Marketing Activities on Pharmaceutical Detailing ROI. DMA Analytics Annual Journal, 29-36
    Kalyanaram, G. (2009). The endogenous modeling of the effect of direct-to-consumer advertising in prescription drugs, International Journal of Pharmaceutical and Healthcare Marketing, 3(2), 137-48.
    Kvesic, D.Z. (2008). Product life cycle management: marketing strategies for the pharmaceutical industry. Journal of medical marketing. 8(4), 293-301.
    Kremer, S., T., Bijmolt, T., H., Leeflang, P., Wieringa, J. (2008). Generalizations on the effectiveness of pharmaceutical promotional expenditures. Int J of Research in Marketing, 25(4), 234-246.
    Lehman, Donald R. (2002). Linking Marketing Decisions to Financial Performance and Firm Value,” MSI Executive Overview,March , 1-5.
    Ling, D. C., Berndt, E. R., & Kyle, M. K. (2002). Deregulating direct-to-consumer marketing of prescription drugs: effects on prescription and over-the-counter product sales. Journal of Law and Economics, 45(2), 691−723.
    Lin, L.J., Cheng, M.H., Lee, C.H., Wung, D.C., Cheng, C.L., Kao, Yang, Y.H. (2008). Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation – a nationwide descriptive study in Taiwan. Clin Ther, 30(9), 1726–1736.
    Mack J., Why pharmaceutical marketers ignore ROI? (2008) Pharma Marketing News (June/July).
    Manchanda, P., Rossi, P. E., & Chintagunta, P. K. (2004a). Response modeling with nonrandom marketing-mix variables. Journal of Marketing Research, 41(4), 467−478.
    Manchanda, P., Dong, X. J., Chintagunta, P. K. (2004b). A Multicategory Model of Physician Prescription Behavior. Working Paper, University of Chicago.
    Manchanda, P.,Wittink,D.R.,Ching, A., Cleanthous, P., Ding,M.,Dong, X. J. J., Leeflang, P. S. H.,Misra, S.,Mizik, N., Narayanan, S., Steenburgh, T.,Wieringa, J. E.,Wosinska,M., & Xie, Y.(2005). Understanding firm, physician and consumer choice behavior in the pharmaceutical industry. Marketing Letters, 16(3–4), 293−308.
    Manchanda, P., Xie, Y., & Youn, N. (2007). The role of targeted communication and contagion in product adoption. Working paper, University of Chicago, Rutgers University, and University of Washington.
    Miller, R. (1973). Prescribing Habits of Physicians: A Review of Studies on Prescribing of Drugs, Ann Pharmacother, 7, 557-564
    Mizik, N., & Jacobson, R. (2004). Are physicians “easy marks”? Quantifying the effects of detailing and sampling on newprescriptions. Management Science, 50(12), 1704−1715.
    Mukherji, P. (2004). Estimating the effects of direct-to-consumer advertising for prescription medicines: a natural experiment. Marketing Science Conference, Rotterdam Proceedings, 48.
    Narayanan, S., Desiraju, R., & Chintagunta, P. K. (2004). Return on investment implications for pharmaceutical promotional expenditures: the role of marketing-mix interactions. Journal of Marketing, 68(4), 90−105.
    Narayanan, Sridhar, Puneet Manchanda, and Pradeep K. Chintagunta. (2005). Temporal Differences in the Role of Marketing Communication in New Products Categories. Journal of Marketing Research 42(August), 278–290.
    Neslin, S. (2001). ROI Analysis of Pharmaceutical Promotion: An Independent Study. unpublished study conducted for the Association of Medical Publications.
    Parsons, L. J., & Vanden Abeele, P. (1981). Analysis of sales call effectiveness. Journal of Marketing Research, 18(1), 107−113.
    Potpara, T. S., & Lip, G.Y. (2011). Lone atrial fibrillation: what is known and what is to come. Int J Clin Pract, 65, 446–457.
    Singh, T., and Smith, D. (2005). Direct-to-consumer prescription drug advertising: a study of consumer attitudes and behavioral intentions. Journal of Consumer Marketing, 22, 369−378.
    Stremersch, S., & Van Dyck,W. (2008). Marketing of the life sciences: A new framework and research agenda for a nascent field. Working paper, Erasmus University Rotterdam and Tilburg University.
    Venkataraman, S., & Stremersch, S. (2007). The debate on influencing doctors` decisions: are drug characteristics the missing link? Management Science, 53(11), 1688−1701.
    Wieringa, J., Leeflang, P., Ruiz E. & Wittink, D. (2004). Longitudinal and cross-sectional effects of marketing instruments on diffusion of pharmaceuticals. 33rd EMAC Conference Murcia Proceedings, 163.
    Wittink, D. R. (2002). Analysis of ROI for pharmaceutical promotion (ARPP). Presentation to the Association of Medical Publications.
    描述: 碩士
    國立政治大學
    國際經營管理英語碩士學位學程(IMBA)
    98933024
    101
    資料來源: http://thesis.lib.nccu.edu.tw/record/#G0098933024
    資料類型: thesis
    顯示於類別:[國際經營管理英語碩士學程IMBA] 學位論文

    文件中的檔案:

    檔案 大小格式瀏覽次數
    index.html0KbHTML2585檢視/開啟


    在政大典藏中所有的資料項目都受到原著作權保護.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋